► Oncology  ► Disease progression and treatment optimization   ► Rituximab

Rituximab 

Test
   PGxPredict™: Rituximab 
Related to
   B cell Lymphoma of cells with specific markers (CD20 expression)
Target population
   Lymphoma patients intended to be treated with Rituximab
Objective
   To assess the patient’s potential benefit from Rituximab while predicting treatment response
Sample type
   Blood sample
Procedure
   Molecular diagnosis of tumor cells
Availability
   Available